Royalty Pharma plc Common Stock, Dividends, Per Share, Cash Paid
Royalty Pharma plc (RPRX) reported Common Stock, Dividends, Per Share, Cash Paid of $0.23 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareCashPaid · last filed 2026-08-05
- Royalty Pharma plc common stock, dividends, per share, cash paid for the quarter ending 2026-06-30 was $0.23, a 6.82% increase year-over-year.
- Royalty Pharma plc common stock, dividends, per share, cash paid for the quarter ending 2026-03-31 was $0.23, a 6.82% increase year-over-year.
- Royalty Pharma plc common stock, dividends, per share, cash paid for the quarter ending 2025-12-31 was $0.22, a 4.76% increase year-over-year.
- Royalty Pharma plc common stock, dividends, per share, cash paid for the quarter ending 2025-09-30 was $0.22, a 4.76% increase year-over-year.
- Royalty Pharma plc common stock, dividends, per share, cash paid for fiscal 2024 was $0.84, a 5.00% increase from fiscal 2023.
- Royalty Pharma plc common stock, dividends, per share, cash paid for fiscal 2023 was $0.80, a 5.26% increase from fiscal 2022.
- Royalty Pharma plc common stock, dividends, per share, cash paid for fiscal 2022 was $0.76, a 11.76% increase from fiscal 2021.
- Royalty Pharma plc common stock, dividends, per share, cash paid for fiscal 2021 was $0.68, a 126.67% increase from fiscal 2020.
| Period end | Common Stock, Dividends, Per Share, Cash Paid 3 month | Common Stock, Dividends, Per Share, Cash Paid 6 month | Common Stock, Dividends, Per Share, Cash Paid 9 month | Common Stock, Dividends, Per Share, Cash Paid 12 month | Common Stock, Dividends, Per Share, Cash Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.23 10-Q · filed 2026-08-05 | $0.47 derived: sum of 2 quarters · filed 2026-08-05 | $0.69 derived: sum of 3 quarters · filed 2026-08-05 | $0.91 derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $0.23 10-Q · filed 2026-08-05 | $0.45 derived: sum of 2 quarters · filed 2026-08-05 | $0.68 derived: sum of 3 quarters · filed 2026-08-05 | $0.90 derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $0.22 10-K · filed 2026-02-11 | $0.44 derived: sum of 2 quarters · filed 2026-02-11 | $0.66 derived: sum of 3 quarters · filed 2026-02-11 | $0.88 derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-09-30 | $0.22 10-K · filed 2026-02-11 | $0.44 derived: sum of 2 quarters · filed 2026-02-11 | $0.66 derived: sum of 3 quarters · filed 2026-02-11 | $0.87 derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-06-30 | $0.22 10-K · filed 2026-02-11 | $0.44 derived: sum of 2 quarters · filed 2026-02-11 | $0.65 derived: sum of 3 quarters · filed 2026-02-11 | $0.86 derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-03-31 | $0.22 10-K · filed 2026-02-11 | $0.43 derived: sum of 2 quarters · filed 2026-02-11 | $0.64 derived: sum of 3 quarters · filed 2026-02-11 | $0.85 derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-12-31 | $0.21 10-K · filed 2025-02-12 | $0.42 derived: sum of 2 quarters · filed 2025-02-12 | $0.63 derived: sum of 3 quarters · filed 2025-02-12 | $0.84 10-K · filed 2025-02-12 | |
| 2024-09-30 | $0.21 10-K · filed 2025-02-12 | $0.42 derived: sum of 2 quarters · filed 2025-02-12 | $0.63 derived: sum of 3 quarters · filed 2025-02-12 | $0.83 derived: sum of 4 quarters · filed 2025-02-12 | |
| 2024-06-30 | $0.21 10-K · filed 2025-02-12 | $0.42 derived: sum of 2 quarters · filed 2025-02-12 | $0.62 derived: sum of 3 quarters · filed 2025-02-12 | $0.82 derived: sum of 4 quarters · filed 2025-02-12 | |
| 2024-03-31 | $0.21 10-K · filed 2025-02-12 | $0.41 derived: sum of 2 quarters · filed 2025-02-12 | $0.61 derived: sum of 3 quarters · filed 2025-02-12 | $0.81 derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-12-31 | $0.20 10-K · filed 2024-02-15 | $0.40 derived: sum of 2 quarters · filed 2024-02-15 | $0.60 derived: sum of 3 quarters · filed 2024-02-15 | $0.80 10-K · filed 2025-02-12 | |
| 2023-09-30 | $0.20 10-K · filed 2024-02-15 | $0.40 derived: sum of 2 quarters · filed 2024-02-15 | $0.20 10-Q · filed 2023-11-08 | $0.79 derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-06-30 | $0.20 10-K · filed 2024-02-15 | $0.20 10-Q · filed 2023-08-08 | $0.59 derived: sum of 3 quarters · filed 2024-02-15 | $0.78 derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-03-31 | $0.20 10-K · filed 2024-02-15 | $0.39 derived: sum of 2 quarters · filed 2024-02-15 | $0.58 derived: sum of 3 quarters · filed 2024-02-15 | $0.77 derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-12-31 | $0.19 10-K · filed 2023-02-15 | $0.38 derived: sum of 2 quarters · filed 2023-02-15 | $0.57 derived: sum of 3 quarters · filed 2023-02-15 | $0.76 10-K · filed 2025-02-12 | |
| 2022-09-30 | $0.19 10-K · filed 2023-02-15 | $0.38 derived: sum of 2 quarters · filed 2023-02-15 | $0.19 10-Q · filed 2022-11-08 | $0.74 derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-06-30 | $0.19 10-K · filed 2023-02-15 | $0.19 10-Q · filed 2022-08-04 | $0.55 derived: sum of 3 quarters · filed 2023-02-15 | $0.72 derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-03-31 | $0.19 10-K · filed 2023-02-15 | $0.36 derived: sum of 2 quarters · filed 2023-02-15 | $0.53 derived: sum of 3 quarters · filed 2023-02-15 | $0.70 derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-12-31 | $0.17 10-K · filed 2022-02-15 | $0.34 derived: sum of 2 quarters · filed 2022-11-08 | $0.51 derived: sum of 3 quarters · filed 2022-11-08 | $0.68 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.17 10-Q · filed 2022-11-08 | $0.34 derived: sum of 2 quarters · filed 2022-11-08 | $0.17 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.17 10-Q · filed 2022-08-04 | $0.17 10-Q · filed 2021-08-11 | |||
| 2021-03-31 | $0.17 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $0.30 10-K · filed 2023-02-15 | $0.15 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |